Dr. Alyssa Vanwerden, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1105 S College Mall Rd, Bloomington, IN 47401 Phone: 812-333-2020 Fax: 812-334-2020 |
First Impressions Optometric Associates, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2894 E 3rd St Ste 155, Bloomington, IN 47401 Phone: 812-336-2702 Fax: 812-336-2705 |
Brett Joseph King, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 744 E 3rd St, Bloomington, IN 47405 Phone: 812-855-1344 Fax: 812-855-1683 |
Dr. Zachary C Short, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 415 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-849-4555 Fax: 812-849-2842 |
Robert C. Gammon, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2600 W 3rd St, Bloomington, IN 47404 Phone: 812-336-5432 |
Patricia A Henderson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 744 E Atwater Ave, Bloomington, IN 47401 Phone: 812-855-8436 |
Dr. Todd David Peabody, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 E Atwater Ave, Bloomington, IN 47405 Phone: 812-855-8436 Fax: 812-855-1683 |
Raymond Alex Chartier, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 744 E 3rd St, Bloomington, IN 47405 Phone: 812-855-8436 |
Dr. Madison Jo Witthoft, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 415 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-333-1911 |
Dr. Margaret S Mccalla-jackson, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2600 W 3rd St, Bloomington, IN 47404 Phone: 812-336-5432 Fax: 812-332-5084 |
John P Downey, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 800 E Atwater Ave, Bloomington, IN 47405 Phone: 812-855-4447 |
Dr. Katie Shulist Connolly, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 744 E 3rd St, Bloomington, IN 47405 Phone: 812-855-8436 |
Atwater Eye Care Center Optometrist Medicare: Medicare Enrolled Practice Location: 744 E 3rd St, Bloomington, IN 47405 Phone: 812-855-8436 Fax: 812-856-1683 |
Dr. Peter S Kollbaum, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 800 E Atwater Ave, Bloomington, IN 47405 Phone: 812-855-4447 |
Dr. Jeffrey D. Perotti, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 E Atwater Ave, Bloomington, IN 47405 Phone: 812-855-4447 |
Dr Kristina Morris Llc Optometrist Medicare: Medicare Enrolled Practice Location: 4619 W Richland Plaza Dr, Bloomington, IN 47404 Phone: 812-332-3937 Fax: 812-336-7697 |
Thomas Gast Optometrist Medicare: Not Enrolled in Medicare Practice Location: 414 S Meadowbrook Dr, Bloomington, IN 47401 Phone: 812-391-2545 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 W Kirkwood Ave, Bloomington, IN 47404 Phone: 812-331-9082 Fax: 812-331-1301 |
I-care Bloomington Inc Optometrist Medicare: Medicare Enrolled Practice Location: 3205 W State Road 45, Bloomington, IN 47403 Phone: 812-333-8912 Fax: 812-333-8918 |
Dr. Diana Lynn Christensen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3205 West State Road 45, Christensen Eye Care, Bloomington, IN 47403 Phone: 812-333-8912 Fax: 812-333-8918 |
News Archive
Children and young adult thyroid cancer patients who are treated with radioactive iodine have an elevated risk of developing a second primary malignancy, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.
The state is seeking another $40 million for operation costs. Meanwhile, in Illinois, the Quinn administration filed plans to award the contract to build the state's online insurance marketplace.
› Verified 9 days ago